Insights

Choate Ranks Highly in 2024 Legal 500

The 2024 edition of The Legal 500 recognized 40 Choate attorneys in their respective fields and 10 practice areas.

Choate Lawyers and Practice Groups Recognized by Chambers 2024

The 2024 edition of Chambers USA Guide to America’s Leading Lawyers for Business recognized 34 Choate attorneys as leading counsel in their respective fields, with seven receiving Band 1 rankings.

BV Investment Partners Announces Investment in Balance Partners

Choate represented BV Investment Partners in its investment in Balance Partners, a specialty insurance managing general agency.

Lydonia Technologies Secures Investment from Caltius Equity Partners

Choate represented Lydonia Technologies, a leading provider of AI-powered hyperautomation software and solutions, in its investment from Caltius Equity Partners.

2024 Hart-Scott-Rodino Requirements

Hart-Scott-Rodino (HSR) filing thresholds will be adjusted upward effective March 6, 2024, and for parties involved in a merger or acquisition these adjustments may affect whether a company is required to make a premerger notification filing in any given transaction.

M/C Partners Announces Growth Investment in AccessParks

Choate represented M/C Partners in a significant growth investment in AccessParks, which provides high-performance broadband connectivity to RV parks, national and state parks, and manufactured housing communities across the United States.

CPBS Holdings Acquired by Avantik

Choate represented Copley Equity Partners and its portfolio company, CPBS Holdings, in the sale of CPBS Holdings to Avantik, an integrated medical products and services provider to anatomic pathology, histology, and dermatology laboratories.

DOXA Insurance Holdings to be Acquired by Goldman Sachs

Choate represented Century Equity Partners in the sale of its portfolio company, DOXA Insurance Holdings, to Goldman Sachs Asset Management.

FTC Files Antitrust Charges Against a Private Equity Sponsor

The current FTC leadership has been making strong statements against private equity roll-ups across industry sectors, and on September 21, 2023, acted on this rhetoric by suing a large health care provider in Texas, along with its founding private equity sponsor.